Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

February 28, 2011

Conditions
Non Small Cell Lung Cancer
Trial Locations (24)

Unknown

Research Site, Santiago de Compostela

Research Site, Albacete

Research Site, Alicante

Research Site, Elche

Research Site, Barcelona

Research Site, Cáceres

Research Site, Santander

Research Site, Córdoba

Research Site, Girona

Research Site, Granada

Research Site, Jaén

Research Site, Lugo

Research Site, Madrid

Research Site, Málaga

Research Site, Murcia

Research Site, Pamplona

Research Site, Pontevedra

Research Site, Vigo

Research Site, Oviedo

Research Site, Salamanca

Research Site, Seville

Research Site, Reus

Research Site, Valencia

Research Site, Zaragoza

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY